# BPC-157 / TB-500 Blend

> This blend combines BPC-157, a synthetic peptide based on a partial sequence of a gastric-protective compound, with TB-500, a synthetic analog of the naturally occurring protein thymosin beta-4. It is one of the most widely referenced combined-peptide research protocols for soft-tissue recovery, pairing two peptides that are individually studied in preclinical and animal models for tissue repair, angiogenesis, and modulation of inflammation. Interest in combining them centers on the idea that BPC-157's localized gut- and tendon-related effects and TB-500's broader systemic tissue-repair signaling may address injury from complementary angles. Evidence for the fixed combination itself is limited; most available data comes from studies of each peptide separately rather than trials of the blend. It is not approved for human medical use, and claims about its effects should be considered preliminary.

- URL: https://www.lifeconverted.com/peptides/bpc157-tb500-blend
- Also known as: BPC-157/TB-500 Stack, Wolverine Blend
- Primary category: Healing Blends
- Effectiveness rank: #5 in Healing & Recovery; #1 in Healing Blends
- Evidence level: Well studied
- Route: Subcutaneous (Typically injected subcutaneously into abdominal fat; some informal protocols place the BPC-157 portion closer to an injured joint or tendon, since TB-500 is proposed to act more systemically regardless of injection site.)
- Dose range: 250-750 mcg
- Dose tiers: low 250 mcg; moderate 500 mcg; high 750 mcg
- Half-life: The two components differ substantially: BPC-157 is reported at roughly 4 hours, while TB-500 is described as persisting for a much longer duration, on the order of days, despite both being injected in the same shot.
- Timing: Morning, or split AM/PM
- Cycle: 4-6 weeks on, 2-4 weeks off (Often cycled to align with the expected healing window of a specific injury rather than used on an ongoing basis.)
- Storage: Refrigerate after reconstitution (2-8°C) and protect from light. Most compounded versions are described as stable for 3-4 weeks.

## Mechanism of action

BPC-157 is studied for its proposed influence on angiogenesis and fibroblast activity at sites of tissue damage, partly through modulation of growth-factor and nitric-oxide signaling pathways. TB-500 is an actin-binding peptide thought to support the migration of repair-related cells, such as fibroblasts and endothelial cells, to injured tissue. Researchers combining the two describe the pairing as targeting both localized structural repair (BPC-157) and broader cell-migration and angiogenic support (TB-500), though the two mechanisms have not been directly compared in a single controlled study.

## Reported benefits

- Supports tendon and ligament tissue repair in preclinical research
- Associated with reduced local inflammation
- Studied for gut-lining and soft-tissue recovery
- Frequently used as a general injury-recovery research pairing

## Reported side effects

- Mild nausea
- Head rush or lightheadedness
- Injection site redness or irritation
- Lethargy (more often reported with TB-500)

## Common protocols

- Recovery Stack
- Post-Injury Protocol
- Tendon & Ligament Repair

## Stacking notes

Considered a foundational pairing in injury-recovery research; sometimes extended with GHK-Cu for skin- or collagen-focused protocols (see GLOW Blend) or further layered with KPV (see KLOW Blend).

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer